Journal of Digestive Cancer Research

Korean Society of Gastrointestinal Cancer Research (대한소화기암연구학회)
권호 표지
DOI QR코드

DOI QR Code

Systematic Review of Research Progress on Borderline Resectable Pancreatic Cancer: A Bibliometric and Visualized Analysis

경계성 절제가능형 췌장 연구 동향에 대한 체계적인 문헌 고찰: 계량서지학적 분석 및 시각화된 분석

  • Jae Keun Park (Division of Gastroenterology and Hepatology, Department of Internal Medicine, Hallym University Kangnam Sacred Heart Hospital) ;
  • Ji Woong Hwang (Department of Surgery, Chung-Ang University Gwangmyeong Hospital, Chung-Ang University College of Medicine)
  • 박재근 (한림대학교 강남성심병원 내과학교실 소화기내과) ;
  • 황지웅 (중앙대학교 의과대학 중앙대학교광명병원 외과)
  • Received : 2024.04.15
  • Accepted : 2024.04.18
  • Published : 2024.04.20
Download PDF
⟨ Previous Next ⟩

Abstract

Borderline resectable pancreatic cancer, an intermediate stage between a completely resectable state and an unresectable state, requires a multidisciplinary treatment approach. This study aimed to elucidate the main characteristics and recent research trends regarding borderline resectable pancreatic cancer to gain further insights into them. Data from published papers about borderline resectable pancreatic cancer were collected from Web of Science (2014-2023) for the analysis. This study included 355 papers; data on major countries, publishing organizations, and keywords were collected and analyzed. Furthermore, R studio and VOSviewer were used for the qualitative and quantitative analyses of keywords. Publication of papers on borderline resectable pancreatic cancer was observed to be increasing annually by 12.8%, with the United States and Japan being the main publishing countries. In 2014, keywords related to surgery and chemotherapy were dominant; however, a shift toward more integrative approaches, such as neoadjuvant therapy, was observed over time. This study demonstrates rapidly evolving trends and paradigm changes in the research and management of borderline resectable pancreatic cancer. Thus, the results of this study are expected to contribute to establishing future research strategies and improving patient treatment outcomes.

Keywords

References

  1. Mehta VK, Fisher G, Ford JA, et al. Preoperative chemoradiation for marginally resectable adenocarcinoma of the pancreas. J Gastrointest Surg 2001;5:27-35. https://doi.org/10.1016/s1091-255x(01)80010-x
  2. Stoop TF, Theijse RT, Seelen LWF, et al. Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer. Nat Rev Gastroenterol Hepatol 2024;21:101-124. https://doi.org/10.1038/s41575-023-00856-2
  3. Hajibandeh S, Hajibandeh S, Intrator C, et al. Neoadjuvant chemoradiotherapy versus immediate surgery for resectable and borderline resectable pancreatic cancer: meta-analysis and trial sequential analysis of randomized controlled trials. Ann Hepatobiliary Pancreat Surg 2023;27:28-39. https://doi.org/10.14701/ahbps.22-052
  4. Huan L, Yu F, Cao D, Zhou H, Qin M, Cao Y. Comparison of neoadjuvant treatment and surgery first for resectable or borderline resectable pancreatic carcinoma: a systematic review and network meta-analysis of randomized controlled trials. PLoS One 2024;19:e0295983. https://doi.org/10.1371/journal.pone.0295983
  5. Kwasniewska D, Fudalej M, Nurzynski P, et al. How a patient with resectable or borderline resectable pancreatic cancer should be treated-a comprehensive review. Cancers (Basel) 2023;15:4275. https://doi.org/10.3390/cancers15174275
  6. Luukkonen T. Invited Review Article: Bibliometrics and evaluation of research performance. Ann Med 1990;22:145-150. https://doi.org/10.3109/07853899009147259
  7. Park S, Bekemeier B, Flaxman A, Schultz M. Impact of data visualization on decision-making and its implications for public health practice: a systematic literature review. Inform Health Soc Care 2022;47:175-193. https://doi.org/10.1080/17538157.2021.1982949
  8. Ahn SK, Hwang JW. Global trends in immunotherapy research on breast cancer over the past 10 years. J Oncol 2020;2020:4708394. https://doi.org/10.1155/2020/4708394
  9. Kim H, Shin SP, Hwang JW, Lee JW. Outcomes of laparoscopic common bile duct exploration (LCBDE) after failed endoscopic retrograde cholangiopancreatography versus primary LCBDE for managing cholecystocholedocholithiasis. J Int Med Res 2020;48:300060520957560. https://doi.org/10.1177/0300060520957560
  10. Lee K, Hwang JW, Sohn HJ, Suh S, Kim SW. A systematic review of progress on hepatocellular carcinoma research over the past 30 years: a machine-learning-based bibliometric analysis. Front Oncol 2023;13:1227991. https://doi.org/10.3389/fonc.2023.1227991
  11. Bockhorn M, Uzunoglu FG, Adham M, et al. Borderline resectable pancreatic cancer: a consensus statement by the International Study Group of Pancreatic Surgery (ISGPS). Surgery 2014;155:977-988. https://doi.org/10.1016/j.surg.2014.02.001
  12. Park JK, Hwang JW. Research progress and future directions on intraductal papillary mucinous neoplasm: a bibliometric and visualized analysis of over 30 years of research. Medicine (Baltimore) 2023;102:e33568. https://doi.org/10.1097/MD.0000000000033568
  13. Takahashi S. How to treat borderline resectable pancreatic cancer: current challenges and future directions. Jpn J Clin Oncol 2018;48:205-213. https://doi.org/10.1093/jjco/hyx191
  14. de Scordilli M, Michelotti A, Zara D, et al. Preoperative treatments in borderline resectable and locally advanced pancreatic cancer: current evidence and new perspectives. Crit Rev Oncol Hematol 2023;186:104013. https://doi.org/10.1016/j.critrevonc.2023.104013